MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028
TABLE OF CONTENTS
1. MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON HORMONE
REPLACEMENT THERAPY MARKET
2.2. KEY INSIGHTS
1.1.1. INTRODUCTION OF NEW DRUG DELIVERY
SYSTEMS FOR HORMONE REPLACEMENT
1.1.2. MODERN SEDENTARY LIFESTYLES
1.2. PORTER’S FIVE FORCES MODEL
1.1.1. THREAT OF NEW ENTRANTS
1.1.2. THREAT OF SUBSTITUTE PRODUCTS
1.1.3. BARGAINING POWER OF BUYERS
1.1.4. BARGAINING POWER OF SUPPLIERS
1.1.5. COMPETITIVE RIVALRY
1.2. MARKET ATTRACTIVENESS INDEX
1.3. VENDOR SCORECARD
1.4. KEY STRATEGIC DEVELOPMENTS
1.1.1. ACQUISITIONS & MERGERS
1.1.2. PRODUCT LAUNCH & DEVELOPMENTS
1.1.3. CONTRACTS AND PARTNERSHIPS
1.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS,
& DIVESTITURES
1.2. MARKET DRIVERS
1.1.1. RISE IN AWARENESS PERTAINING TO
HEALTH PROBLEMS DURING MENOPAUSE
1.1.2. INCREASE IN PREVALENCE OF HORMONAL
DISORDERS
1.1.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS
1.2. MARKET RESTRAINTS
1.1.1. HIGH COST OF TREATMENT
1.1.2. ADVERSE REACTIONS ASSOCIATED WITH
HORMONE REPLACEMENT THERAPY
1.2. MARKET OPPORTUNITIES
1.1.1. AVAILABILITY OF ALTERNATIVE THERAPY
OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
1.1.2. LAUNCH OF TELEMEDICINE CLINICAL
PRACTICE SERVICES
2. MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
2.1. ESTROGEN HORMONE REPLACEMENT THERAPY
2.2. THYROID HORMONE REPLACEMENT THERAPY
2.3. TESTOSTERONE HORMONE REPLACEMENT
THERAPY
2.4. HUMAN GROWTH HORMONE REPLACEMENT
THERAPY
2.5. PROGESTOGEN HORMONE REPLACEMENT
THERAPY
3. MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
3.1. MENOPAUSE
3.2. MALE HYPOGONADISM
3.3. GROWTH HORMONE DEFICIENCY
3.4. HYPOTHYROIDISM
3.5. OTHER TYPE OF DISEASES
4. MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. PARENTERAL
4.3. TRANSDERMAL
4.4. OTHER ROUTES OF ADMINISTRATION
5. MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK
1.1.1. SAUDI ARABIA
1.1.2. UNITED ARAB EMIRATES
1.1.3. TURKEY
1.1.4. SOUTH AFRICA
1.1.5. REST OF MIDDLE EAST & AFRICA
2. COMPETITIVE LANDSCAPE
1.1. ABBOTT LABORATORIES
1.2. AMGEN
1.3. ANI PHARMACEUTICALS
1.4. BAYER AG
1.5. DR REDDY’S LABORATORIES LTD
1.6. ELI LILLY & COMPANY
1.7. GENENTECH INC
1.8. IPSEN
1.9. MERCK KGAA
1.10.
NOVARTIS AG
1.11.
NOVEN PHARMACEUTICALS INC
1.12.
NOVO NORDISK A/S
1.13.
PFIZER INC
1.14.
TEVA PHARMACEUTICAL INDUSTRIES LTD
1.15.
VIATRIS INC (MYLAN NV)
2. RESEARCH METHODOLOGY & SCOPE
2.1. RESEARCH SCOPE & DELIVERABLES
1.1.1. OBJECTIVES OF STUDY
1.1.2. SCOPE OF STUDY
1.2. SOURCES OF DATA
1.2.1. PRIMARY DATA SOURCES
1.2.2. SECONDARY DATA SOURCES
1.3. RESEARCH METHODOLOGY
1.3.1. EVALUATION OF PROPOSED MARKET
1.3.2. IDENTIFICATION OF DATA SOURCES
1.3.3. ASSESSMENT OF MARKET DETERMINANTS
1.3.4. DATA COLLECTION
1.3.5.
DATA VALIDATION & ANALYSIS
LIST OF TABLES
TABLE 1: MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
& MERGERS
TABLE 4: LIST OF PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND
PARTNERSHIPS
TABLE 6: MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $
MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $
MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2021-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT
THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT
THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN
$ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $
MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028
(IN %)
FIGURE 15: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION,
2021-2028 (IN $ MILLION)
FIGURE 19: SAUDI ARABIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: UNITED ARAB EMIRATES
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: TURKEY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: SOUTH AFRICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: REST OF MIDDLE EAST
& AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
MARKET OUTLOOK
Triton’s research report signifies that the Middle East and Africa’s
hormone replacement therapy market is evaluated to surge at a CAGR of 7.43%
through the years 2021-2028. South Africa, Saudi Arabia, Turkey, the UAE, and
Rest of Middle East & Africa shape the overall market in the given region.
The development of the modern infrastructure of hormone replacement
therapy hospitals is among the various factors supplementing the growth of the
market in the UAE. Here, the cost of hormone replacement therapy is evaluated
to be relatively lower than the US and the European nations, making it an ideal
destination for hormone therapy treatments. Besides, hormone replacement
therapy hospitals are considered to offer advanced medical facilities with
international level of medical services to the patients. Hence, all these
aforementioned factors are likely to boost the demand for hormone replacement
therapy, augmenting the expansion of the hormone replacement therapy market
across the country.
In Rest of Middle East and Africa, the government initiatives and
launches supporting the growth of hormone therapy are influencing the
development of the studied market. Also, the untapped economies in the region
are showcasing potential growth, largely supporting the reviewed market’s
growth. Other than this, the presence of a large population base also adds to
the growth of the hormone replacement therapy market in the region’s countries,
including Israel and Nigeria.
COMPETITIVE OUTLOOK
Key companies profiled in the hormone
replacement therapy market are Teva Pharmaceutical Industries Ltd, Eli Lilly
& Company, Genentech Inc, Dr Reddy’s Laboratories Ltd, Ipsen, Noven
Pharmaceuticals Inc, and ANI Pharmaceuticals.
Get more insights into the Middle East Africa
Hormone Replacement Therapy Market:
SEGMENTATION
1. ABBOTT LABORATORIES
2. AMGEN
3. ANI PHARMACEUTICALS
4. BAYER AG
5. DR REDDY’S LABORATORIES LTD
6. ELI LILLY & COMPANY
7. GENENTECH INC
8. IPSEN
9. MERCK KGAA
10. NOVARTIS AG
11. NOVEN PHARMACEUTICALS INC
12. NOVO NORDISK A/S
13. PFIZER INC
14. TEVA PHARMACEUTICAL INDUSTRIES LTD
Comments
Post a Comment